omega-3 dziļjūras zivju eļļa ar greipfrūtu sīrupu (2020.) šķidrums
oriental herbs ltd. - šķidrums
lamberts® attīrīta zivju eļļa 1100 mg (2021.) kapsula
lamberts healthcare ltd. - kapsula
omega-3 zivju eļļas kapsulas + d3 (2021.) kapsula
kapsula
augstas koncentrĀcijas zivju eĻĻa (2021.) kapsula
kapsula
d3 vitamĪns dabiskajĀ zivju eĻĻĀ "pērles jūsu veselībai" (2021.) kapsula
kapsula
omega-3 zivju eļļa (2021.) kapsula
kapsula
parene. omega-3 zivju eļļa + vitamīni d3 un e (2023.) kapsula
kapsula
möller`s zivju eĻĻa (2023.) kapsula
kapsula
wellosophy™ omega 3 zivju eļļa (2023.) kapsula
kapsula
imbruvica
janssen-cilag international nv - ibrutinibs - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.